Guidelines for the management of differentiated thyroid carcinomas of vesicular origin.
Borson-Chazot
F
F
francoise.borson-chazot@chu-lyon.fr
Bardet
S
S
Bournaud
C
C
Conte-Devolx
B
B
Corone
C
C
D'Herbomez
M
M
Henry
J-F
JF
Leenhardt
L
L
Peix
J-L
JL
Schlumberger
M
M
Wemeau
J-L
JL
Baudin
E
E
Berger
N
N
Bernard
M-H
MH
Calzada-Nocaudie
M
M
Caron
P
P
Catargi
B
B
Chabrier
G
G
Charrie
A
A
Franc
B
B
Hartl
D
D
Helal
B
B
Kerlan
V
V
Kraimps
J-L
JL
Leboulleux
S
S
Le Clech
G
G
Menegaux
F
F
Orgiazzi
J
J
Perié
S
S
Raingeard
I
I
Rodien
P
P
Rohmer
V
V
Sadoul
J-L
JL
Schwartz
C
C
Tenenbaum
F
F
Toubert
M-E
ME
Tramalloni
J
J
Travagli
J-P
JP
Vaudrey
C
C
D002277:Carcinoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control / Q000628:therapy; D013960:Thyroid Function Tests; D013964:Thyroid Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*
D007457:Iodine Radioisotopes